Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Biotech
Cabaletta’s CAR-T wipes out B cells with no preconditioning
Treatment with rese-cel depleted B cells in three patients with an autoimmune disease, sparking a complete B cell reset in two of them.
Darren Incorvaia
Oct 10, 2025 11:11am
BMS inks $1.5B deal to pull Orbital into its sphere of influence
Oct 10, 2025 8:45am
ARPA-H goes all in on in vivo cell therapy
Oct 8, 2025 4:04pm
ARPA-H invests in Kernal's mRNA cell therapy
Oct 7, 2025 3:20pm
Takeda lays off 137 US staff as part of cell therapy retreat
Oct 1, 2025 3:13pm
ArsenalBio halves staff amid reorganization efforts
Sep 17, 2025 4:55pm
